Sign in

CIK 0000072444 · Accelerated filer<br>Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
591212264
Phone
(650) 550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
  1. DEFA14A Proxy Proxy Materials
  2. DEFA14A Proxy Proxy Materials
  3. DEFA14A Proxy Proxy Materials
  4. DEFA14A Proxy Proxy Materials
  5. DEFA14A Proxy Proxy Materials
  6. DEFA14A Proxy Proxy Materials
  7. DEFA14A Proxy Proxy Materials
  8. S-8 Other Securities Offered to Employees in Benefit Plans
  9. DEFA14A Proxy Proxy Materials
  10. S-3ASR Offering Registration Statement
  11. S-8 Other Securities Offered to Employees in Benefit Plans
  12. DEFA14A Proxy Proxy Materials
  13. DEFA14A Proxy Proxy Materials
  14. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  15. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  16. EFFECT Other Notice of Effectiveness
  17. POS AM Other Post-effective Amendment for Registration Statement
  18. EFFECT Other Notice of Effectiveness
  19. FWP Offering Free Writing Prospectus
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 4 of 12 · 235 filings